GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., Dec. 3, 2024 MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...
GRAIL to Participate in Upcoming Investor Conferences PR Newswire MENLO PARK, Calif., Nov. 19, 2024 MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study PR Newswire MENLO PARK, Calif., Nov. 18, 2024 MENLO PARK, Calif., Nov. 18, 2024 ...
GRAIL Reports Third Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., Nov. 12, 2024 Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed...
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire MENLO PARK, Calif., Nov. 4, 2024 MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.29 | 6.34842519685 | 20.32 | 23.44 | 20.23 | 1019817 | 21.49098919 | CS |
4 | 5.61 | 35.0625 | 16 | 23.44 | 13.58 | 863668 | 18.41947605 | CS |
12 | 7.42 | 52.2903453136 | 14.19 | 23.44 | 12.33 | 712623 | 15.7072752 | CS |
26 | 2.98 | 15.9957058508 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
52 | 2.98 | 15.9957058508 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
156 | 2.98 | 15.9957058508 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
260 | 2.98 | 15.9957058508 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales